XRCC5
Reaktivität: Human
WB, IF
Wirt: Maus
Monoclonal
7-Ku80
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Dedieu, Canron, Rezvani, Bouchecareilh, Mazurier, Sinisi, Zanda, Moenner, Bikfalvi, North: "The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A." in: BMC medicine, Vol. 8, pp. 19, (2010) (PubMed).
Koike: "Dimerization, translocation and localization of Ku70 and Ku80 proteins." in: Journal of radiation research, Vol. 43, Issue 3, pp. 223-36, (2003) (PubMed).
Target
XRCC5
(X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 5 (Double-Strand-Break Rejoining) (XRCC5))